Gregg Stone no longer chairman of Cardiovascular Research Foundation

UpdatedAccording to the website of the Cardiovascular Research Foundation, Gregg Stone is no longer the chairman of CRF. In addition, Stone is identified as the “immediate past chairman” of CRF in the press release for the SPIRIT IV trial issued by Abbott.

As CardioBrief reported yesterday, Stone’s predecessor as chairman, and the founder of the CRF, Martin Leon, was the subject of a letter from Senators Herb Kohl and Charles Grassley regarding potentially undisclosed conflict of interest statements.

CardioBrief has requested comments and background from the CRF, Stone, and other interested parties.

Here is some of the new leadership of CRF, as stated on the CRF website:

Eric B. Woldenberg, Esq. is Chairman of the Board of Directors of the Cardiovascular Research Foundation.  He has been a Partner at Pryor Cashman since 1988, specializes in taxation and estate planning and serves as Chairman of the firm’s Tax Group.

William A. Himmelsbach, MPH, FACHE is President and Chief Executive Officer of the Cardiovascular Research Foundation. Prior to joining CRF, he was Senior Vice President of VHA and Executive Officer of its New York-based VHA Empire – Metro.

George D. Dangas, MD, PhD, is the Director of Academic Affairs and Investigational Pharmacology at the Cardiovascular Research Foundation.

Update: A spokesman for CRF sent the following statement to CardioBrief:

STATEMENT

This past spring, the Cardiovascular Research Foundation announced several important enhancements to its governance and operations structure, to position itself at the forefront of corporate governance principles for nonprofit, charitable medical research organizations.

First, CRF completed a comprehensive review of its organizational structure, governance, and related practices, and compared them against the “best practices” principles of nonprofit corporate governance and ethics that have emerged over the past several years.  In consultation with nationally recognized outside counsel beginning in early 2008, CRF took a series of important actions to assure the strength, independence, and responsiveness of its Board of Directors and administrative leadership, and implemented a series of other governance improvements, all intended to keep the organization consistent with best practices in this area.

Eric B. Woldenberg, Esq., a senior partner in the New York law firm of Pryor Cashman L.L.P., was elected Chairman of the CRF Board of Directors.  Mr. Woldenberg, a noted tax expert, has been a respected member of the Board of Directors since 2007, and brings substantial expertise and independence to the governance leadership of our organization.

Through their key leadership roles in CRF’s Medical Research and Education Division, Gregg W. Stone, M.D. and Martin B. Leon, M.D. devote their time and effort exclusively to the content, quality, and integrity of the foundation’s core research and educational activities.  In this capacity, they bring their internationally renowned clinical and research expertise and experience to bear on initiatives that are essential for the continued advancement of cardiovascular medicine.

===========================================================

Don’t lose touch with CardioBrief. Click here to sign up for a daily email newsletter.

===========================================================

Click here to follow CardioBrief on Twitter and receive instant notification of new posts and links

===========================================================

Speak Your Mind

*